Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ocular Motility Disorders | 1 | 2023 | 37 | 0.800 |
Why?
|
| Strabismus | 1 | 2023 | 65 | 0.780 |
Why?
|
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2007 | 13 | 0.260 |
Why?
|
| Cranial Nerve Diseases | 1 | 2007 | 28 | 0.250 |
Why?
|
| Acetazolamide | 1 | 2023 | 27 | 0.210 |
Why?
|
| Calcium Channels, N-Type | 1 | 2023 | 47 | 0.210 |
Why?
|
| Eye Movements | 1 | 2023 | 69 | 0.200 |
Why?
|
| Calcium Channels | 1 | 2023 | 148 | 0.200 |
Why?
|
| Ataxia | 1 | 2023 | 169 | 0.180 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 1 | 2021 | 10 | 0.180 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2021 | 24 | 0.170 |
Why?
|
| Myasthenia Gravis | 1 | 2021 | 69 | 0.160 |
Why?
|
| Neuromuscular Diseases | 1 | 2020 | 48 | 0.160 |
Why?
|
| Biological Variation, Population | 1 | 2018 | 28 | 0.140 |
Why?
|
| Seizures | 1 | 2023 | 889 | 0.140 |
Why?
|
| Nuclear Proteins | 2 | 2021 | 1226 | 0.140 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2018 | 205 | 0.130 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2021 | 610 | 0.110 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 703 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2021 | 1614 | 0.100 |
Why?
|
| Infant | 3 | 2023 | 13300 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 3411 | 0.080 |
Why?
|
| Mutation | 2 | 2021 | 6177 | 0.080 |
Why?
|
| Facial Paralysis | 1 | 2007 | 35 | 0.060 |
Why?
|
| Deafness | 1 | 2007 | 83 | 0.060 |
Why?
|
| Male | 5 | 2023 | 65158 | 0.060 |
Why?
|
| Humans | 7 | 2023 | 131504 | 0.050 |
Why?
|
| Adolescent | 4 | 2021 | 20917 | 0.050 |
Why?
|
| Pyridostigmine Bromide | 1 | 2021 | 12 | 0.040 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2021 | 66 | 0.040 |
Why?
|
| Myopathy, Central Core | 1 | 2020 | 5 | 0.040 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2020 | 27 | 0.040 |
Why?
|
| Mitochondrial Myopathies | 1 | 2020 | 28 | 0.040 |
Why?
|
| Neural Conduction | 1 | 2020 | 83 | 0.040 |
Why?
|
| Inheritance Patterns | 1 | 2021 | 129 | 0.040 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2020 | 23 | 0.040 |
Why?
|
| Muscular Dystrophies | 1 | 2020 | 52 | 0.040 |
Why?
|
| Prednisone | 1 | 2021 | 244 | 0.040 |
Why?
|
| Electromyography | 1 | 2020 | 141 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 5120 | 0.040 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2021 | 88 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2020 | 226 | 0.040 |
Why?
|
| Phenotype | 2 | 2021 | 4517 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2021 | 15047 | 0.040 |
Why?
|
| Myositis | 1 | 2020 | 105 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2020 | 172 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2021 | 350 | 0.040 |
Why?
|
| De Lange Syndrome | 1 | 2018 | 44 | 0.040 |
Why?
|
| Antigens, Nuclear | 1 | 2018 | 52 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2018 | 96 | 0.030 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2020 | 259 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 134 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2021 | 17648 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 368 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 838 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 1249 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 667 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2018 | 750 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2021 | 929 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 1023 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 934 | 0.030 |
Why?
|
| Child | 3 | 2021 | 26239 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 990 | 0.030 |
Why?
|
| Female | 4 | 2021 | 71087 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 600 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 3911 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 1745 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 2205 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2870 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2021 | 1557 | 0.030 |
Why?
|
| Alleles | 1 | 2018 | 1709 | 0.030 |
Why?
|
| Exome | 1 | 2018 | 1076 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2018 | 1024 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 2355 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 2862 | 0.020 |
Why?
|
| Brain | 1 | 2021 | 3237 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2020 | 8589 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 10092 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2021 | 12936 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 31666 | 0.010 |
Why?
|